cupric chloride has been researched along with penicillamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carru, C; Deiana, L; Pinna, GA; Pisanu, E; Sotgia, S; Zinellu, A | 1 |
| Aggarwal, A; Bhatt, M; Chandhok, G; Horvath, J; Schmidt, HH; Zibert, A | 1 |
| Cui, H; Geraghty, D; Guven, N; Liu, JJ; McKeage, MJ; Nott, LM; Zhang, AJ | 1 |
3 other study(ies) available for cupric chloride and penicillamine
| Article | Year |
|---|---|
Enantiomeric reversed-phase high-performance liquid chromatography resolution of D-/L-penicillamine after spirocyclization with ninhydrin and by using copper(II)-L-proline complex as a chiral selector in the mobile phase.
Topics: Chromatography, High Pressure Liquid; Copper; Ninhydrin; Penicillamine; Proline; Spiro Compounds; Stereoisomerism | 2008 |
Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines.
Topics: Adenosine Triphosphatases; Apoptosis; Carcinoma, Hepatocellular; Cation Transport Proteins; Cell Survival; Chelating Agents; Chlorides; Copper; Copper-Transporting ATPases; Dose-Response Relationship, Drug; Genotype; Hep G2 Cells; Hepatocytes; Hepatolenticular Degeneration; Humans; Liver Neoplasms; Mutation; Penicillamine; Phenotype; Protein Transport; Transfection; Zinc Compounds | 2016 |
Copper transporter 1 in human colorectal cancer cell lines: Effects of endogenous and modified expression on oxaliplatin cytotoxicity.
Topics: Antineoplastic Agents; Cation Transport Proteins; Cell Line, Tumor; Chelating Agents; Copper; Copper Transporter 1; Copper-Transporting ATPases; Drug Synergism; Humans; Molybdenum; Organoplatinum Compounds; Oxaliplatin; Penicillamine; Phenanthrolines; Up-Regulation | 2017 |